No association of DNM3 with age of onset in Asian Parkinson's disease

No association of DNM3 with age of onset in Asian Parkinson's disease

Background: Genetic variability in DNM3 have been shown to modify age of onset of Parkinson’s disease (PD) among LRRK2 Gly2019Ser carriers in North African Arab-Berber populations. In Asian populations, the Gly2019Ser mutation is rare or absent but two other LRRK2 variants Gly2385Arg and Arg1628PPro...

Saved in:

書目詳細資料
Main Authors:	Foo, Jia Nee, Tan, Louis C., Au, Wing-Lok, Prakash, Kumar-M., Liu, Jianjun, Tan, Eng-King
其他作者:	Lee Kong Chian School of Medicine (LKCMedicine)
格式:	Article
語言:	English
出版:	2020
主題:	Science::Biological sciences::Genetics Parkinson's Disease Human Genetics
在線閱讀:	https://hdl.handle.net/10356/141196
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

No association of DNM3 with age of onset in Asian Parkinson's disease
由: Foo J.N., et al.
出版: (2018)

ITPKB and ZNF184 are associated with Parkinson’s disease risk in East Asians
由: Chew, Elaine Guo Yan, et al.
出版: (2020)

Large 3‐Mb deletions at 22q11.2 locus in Parkinson's disease and schizophrenia
由: Foo, Jia Nee, et al.
出版: (2020)

Evaluation of novel Parkinson's disease candidate genes in the Chinese population
由: Chew, Elaine Guo Yan, et al.
出版: (2020)

Genome-wide association study of Parkinson’s disease in East Asians
由: Foo, Jia Nee, et al.
出版: (2020)

Association analysis of PSAP variants in Parkinson's disease patients
由: Chao, Yin Xia, et al.
出版: (2021)

Analysis of EIF4G1 in Parkinson's disease among Asians
由: Zhao, Y., et al.
出版: (2014)

Multi-ancestry genome-wide association meta-analysis of Parkinson's disease
由: Kim, Jonggeol Jeffrey, et al.
出版: (2024)

Genetic testing of LRRK2 in Parkinson's disease: Is there a clinical role?
由: Buhat D.M.L., et al.
出版: (2018)

Screening for TMEM230 mutations in young-onset Parkinson's disease
由: Ma D., et al.
出版: (2018)

Adult-onset re-emergent stuttering as a presentation of Parkinson's disease
由: Lim, E.C.H., et al.
出版: (2011)

Poor sleep quality is associated with fatigue and depression in early Parkinson's disease: a longitudinal study in the PALS cohort
由: Koh, Matthew Rui En, et al.
出版: (2023)

PINK1 mutations in sporadic early-onset Parkinson's Disease
由: Tan E.-K., et al.
出版: (2018)

Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
由: Chao, Y.-X., et al.
出版: (2021)

Functional characterisation of SV2C and its variants as a Parkinson’s Disease-associated gene
由: Chang, Chu-Hua, et al.
出版: (2023)

Identifying genes in Parkinson’s disease : state of the art
由: Chew, Elaine Guo Yan, et al.
出版: (2020)

Clinical evidence linking coffee and tea intake with Parkinson's disease
由: Prakash, K.M., et al.
出版: (2014)

Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk
由: Bialecka M., et al.
出版: (2018)

Linking a genome-wide association study signal to a LRRK2 coding variant in Parkinson's disease
由: Foo J.N., et al.
出版: (2018)

Corrigendum: Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease (Front. Neurol., (2020), 11, (849), 10.3389/fneur.2020.00849)
由: Chao, Y.-X., et al.
出版: (2021)

DNAJ mutations are rare in Chinese Parkinson's disease patients and controls
由: Foo, J.N., et al.
出版: (2014)

Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)
由: Towns, Clodagh, et al.
出版: (2024)

Association of HLA locus variant in parkinson's disease
由: Zhao, Y., et al.
出版: (2014)

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
由: Tan E.K., et al.
出版: (2018)

Altered striatal dopamine levels in Parkinson's disease VPS35 D620N mutant transgenic aged mice
由: Vanan, Sarivin, et al.
出版: (2021)

Factors affecting health-related quality of life amongst Asian patients with Parkinson's disease
由: Zhao, Y.J., et al.
出版: (2011)

Linking statins and lipids in Parkinson's disease
由: Ng A.S.L., et al.
出版: (2018)

Current status of stem cell-derived therapies for Parkinson’s disease : from cell assessment and imaging modalities to clinical trials
由: Jang, Se Eun, et al.
出版: (2021)

Economic burden of Parkinson's disease in Singapore
由: Zhao, Y.J., et al.
出版: (2014)

Development of Parkinson's disease biomarkers
由: Prakash, K.M., et al.
出版: (2014)

Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study
由: Wang L., et al.
出版: (2018)

Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson's disease-associated phenotypes in vivo
由: Hang, Liting, et al.
出版: (2022)

Mitochondrial dysfunction and Parkinson’s disease — near-infrared photobiomodulation as a potential therapeutic strategy
由: Foo, Aaron Song Chuan, et al.
出版: (2021)

Gut-Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease (vol 11, 849, 2020)
由: Chao, Yin-Xia, et al.
出版: (2022)

Trans-Ethnic Fine-Mapping of the Major Histocompatibility Complex Region Linked to Parkinson's Disease
由: Naito, Tatsuhiko, et al.
出版: (2022)

A review on microelectrode recording selection of features for machine learning in deep brain stimulation surgery for Parkinson’s disease
由: Wan, Kai Rui, et al.
出版: (2021)

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
由: Krüger R., et al.
出版: (2018)

Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease
由: Lim S.W., et al.
出版: (2018)

LRRK2 mutations are not frequent in Swiss patients with Parkinson's disease
由: Burgunder, J.-M., et al.
出版: (2011)

MED13 and glycolysis are conserved modifiers of α-synuclein-associated neurodegeneration
由: Ren, Mengda, et al.
出版: (2023)